Search results for "Opium"

showing 10 items of 168 documents

Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with mod…

2015

Background QVA149 is a once-daily (o.d.) inhaled dual bronchodilator containing a fixed-dose combination of the long-acting β2-agonist indacaterol and the long-acting muscarinic antagonist glycopyrronium for the treatment of COPD. The QUANTIFY study compared QVA149 with a free-dose bronchodilator combination of tiotropium plus formoterol (TIO+FOR) in improving health-related quality of life (HRQoL) of patients with COPD. Methods This multicentre, blinded, triple-dummy, parallel-group, non-inferiority study randomised patients aged ≥40 years with moderate-to-severe COPD (post-bronchodilator forced expiratory volume in 1 s (FEV1) ≥30% to <80% predicted) to QVA149 110/50 µg o.d. or TIO 18 µg o…

MalePulmonary and Respiratory MedicineVital capacitymedicine.drug_classChronic Obstructive Pulmonary DiseaseVital CapacityScopolamine DerivativesQuinolonesCOPD PharmacologyDrug Administration SchedulePulmonary Disease Chronic ObstructiveFEV1/FVC ratioDouble-Blind MethodQuality of lifeForced Expiratory VolumeFormoterol FumarateBronchodilatorHumansMedicine1506Tiotropium BromideAdrenergic beta-2 Receptor AgonistsAgedCOPDbusiness.industryMiddle Agedmedicine.diseaseGlycopyrrolateBronchodilator Agentsrespiratory tract diseasesDrug CombinationsTreatment OutcomeEthanolaminesBronchodilator AgentsAnesthesiaIndansQuality of LifeIndacaterolFemaleFormoterolbusinessmedicine.drugThorax
researchProduct

Pooled safety analysis of the fixed-dose combination of indacaterol and glycopyrronium (QVA149), its monocomponents, and tiotropium versus placebo in…

2014

BACKGROUND: To further assess the safety profile of the fixed-dose combination of indacaterol and glycopyrronium (QVA149) and its monocomponents; we investigated the impact of individual patient-level factors and time by integrating the patient-level safety data from the QVA149 clinical programme with relevant information from the independent indacaterol and glycopyrronium safety databases.METHODS: Data from 11,404 patients with chronic obstructive pulmonary disease (COPD) were pooled from 14 clinical studies of QVA149, indacaterol and glycopyrronium of ≥3 month's duration with at least two of the treatment groups: QVA149 110/50 μg, glycopyrronium 50 μg, indacaterol 150 μg, placebo or tiotr…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyFixed-dose combinationScopolamine DerivativesQuinolonesPlaceboPooled analysisPulmonary Disease Chronic ObstructiveRisk FactorsInternal medicinemedicineHumansTiotropium BromideIndacaterolAgedCOPDbusiness.industryTiotropiumHazard ratioQVA149Middle Agedmedicine.diseaseGlycopyrrolateConfidence intervalBronchodilator AgentsDrug CombinationsTreatment OutcomeAnesthesiaIndansIndacaterolDrug Therapy CombinationFemaleGlycopyrroniumSafetybusinessBody mass indexMacemedicine.drugRespiratory Medicine
researchProduct

Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease

2016

Abstract Background Long-term safety, particularly cardiovascular safety, is of special interest in maintenance treatment of chronic obstructive pulmonary disease (COPD) with long-acting β 2 -agonists and long-acting muscarinic antagonists, given potential cardiovascular effects. Methods Two 52-week Phase III trials (TONADO ® ) investigated tiotropium/olodaterol (5/5 and 2.5/5 μg) versus tiotropium 2.5, 5 μg and olodaterol 5 μg. In a pre-specified safety analysis, investigator-reported treatment-emergent adverse events (AEs), electrocardiogram and laboratory data were pooled. All serious AE (SAE) reports were reviewed by an independent Adjudication Committee, which assessed whether deaths, …

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyMedDRAComorbidityMuscarinic AntagonistsPulmonary Disease Chronic Obstructive03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDouble-Blind MethodForced Expiratory VolumeInternal medicineAdministration InhalationmedicineHumans030212 general & internal medicineTiotropium BromideAdverse effectAdrenergic beta-2 Receptor AgonistsAgedCOPDbusiness.industryIncidenceIncidence (epidemiology)OlodaterolTiotropium bromideMiddle Agedmedicine.diseaseComorbidityBenzoxazinesBronchodilator AgentsDrug Combinations030228 respiratory systemchemistryCardiovascular DiseasesAnesthesiaFemalebusinessMaceFollow-Up Studiesmedicine.drug
researchProduct

Lung function and long-term safety of tiotropium/olodaterol in East Asian patients with chronic obstructive pulmonary disease

2017

Background and purpose While the efficacy and safety of combined tiotropium and olodaterol in patients with COPD was established in a large clinical trial program, it is important to assess whether clinical data can be applied to geographic patient groups, particularly for East Asian patients who may have a different phenotypic profile to the global trial population. This study aimed to compare the lung function and safety profiles of tiotropium/olodaterol and monocomponents in East Asian and global populations from the TONADO® trials. Materials and methods In the replicate, double-blind, parallel-group, active-controlled, randomized, 52-week, Phase III TONADO studies, patients received tio…

MaleTime FactorsHealth StatusVital CapacityCholinergic AntagonistsPulmonary function testingPulmonary Disease Chronic Obstructivechemistry.chemical_compound0302 clinical medicineForced Expiratory Volume030212 general & internal medicineLungLung functionOriginal ResearchCOPDeducation.field_of_studypulmonary functionOlodaterolArea under the curveGeneral MedicineMiddle AgedhumanitiesBronchodilator AgentsDrug CombinationsTreatment OutcomeArea Under CurveFemaleChinamedicine.medical_specialtyPopulationInternational Journal of Chronic Obstructive Pulmonary Disease03 medical and health sciencesAsian PeopleDouble-Blind MethodInternal medicinemedicineHumansCOPDTiotropium BromideAdverse effecteducationAdrenergic beta-2 Receptor AgonistsAgedbusiness.industryRecovery of Functionmedicine.diseaseBenzoxazinesrespiratory tract diseasesClinical trial030228 respiratory systemchemistryQuality of Lifeadverse effectsTONADO®businesshuman activitiesInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study

2016

R&amp;uuml;diger Sauer,1 Michaela H&amp;auml;nsel,2 Roland Buhl,3 Roman A Rubin,4 Marcel Frey,5 Thomas Glaab2,3 1Lung Centre Ulm, Ulm, Germany; 2Boehringer Ingelheim Pharma GmbH&amp;nbsp;&amp;amp; Co. KG, Ingelheim, Germany; 3Pulmonary Department, Mainz University Hospital, Mainz, Germany; 4Pulmonary Specialist Practice, Wiesbaden, Germany; 5Biometrics, Alcedis GmbH, Gie&amp;szlig;en, Germany Background: Maintaining and improving physical functioning is key to mitigating the cycle of deconditioning associated with chronic obstructive pulmonary disease (COPD). We evaluated the impact of free combination of the long-acting anticholinergic tiotropium plus the long-acting &amp;beta;2-agonist ol…

Malereal-worldTime FactorsnoninterventionalHealth StatusSeverity of Illness IndexCholinergic AntagonistsPulmonary Disease Chronic Obstructivechemistry.chemical_compound0302 clinical medicinetiotropiumDeconditioningPhysical functioningSurveys and QuestionnairesProspective Studies030212 general & internal medicineLungOriginal ResearchCOPDOlodaterolGeneral MedicineTiotropium bromideMiddle AgedBronchodilator AgentsDrug CombinationsTreatment OutcomeFemalemedicine.drugmedicine.medical_specialtymedicine.drug_classInternational Journal of Chronic Obstructive Pulmonary Diseasechronic obstructive pulmonary disease03 medical and health sciencesAdministration InhalationSeverity of illnessmedicineAnticholinergicphysical functioningHumansTiotropium BromideIntensive care medicineAdrenergic beta-2 Receptor AgonistsAgedolodaterolbusiness.industryNebulizers and VaporizersRecovery of Functionmedicine.diseaseBenzoxazines030228 respiratory systemchemistryPhysical therapyObservational studybusinessInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Perylenetetracarboxylic anhydride as a precursor of fluorescent carbon nanoonion rings

2015

[EN] Thermal annealing at 400 degrees C of perylenetetracarboxylic anhydride in low molecular mass PEG gives rise to the formation of well defined nanoobjects of 2.5 nm height and size distribution from 10 to 65 nm (average 40 nm) after purification of the raw mixture with silicagel chromatography. TEM reveals that the flat nanoobjects are constituted of concentric graphenic rings (0.34 nm interlayer distance). The morphology of the nanoparticles resembles onion rings of nanometric dimensions (nanoonion rings C-NOR). C-NOR particles have an excitation dependent emission with lambda(em) from 430 to 570 nm and a maximum emission quantum yield of 0.49. C-NOR particles can be internalized into …

Materials scienceCell SurvivalPolymerschemistry.chemical_elementNanoparticleQuantum yieldBiocompatible MaterialsPhotochemistryMicroscopy Atomic ForceIn-vitroQUIMICA ORGANICAComplexesEuropiumCell Line TumorSpectroscopy Fourier Transform InfraredOnionsFluorescence microscopeOrganic chemistryHumansFluorescentGeneral Materials ScienceHigh-pressureschemistry.chemical_classificationCarbon nanoonion ringQuantum dotsPolymerFluorescenceCarbonDynamic Light ScatteringHydrocarbonsNanostructuresPhotoluminiscencechemistryMicroscopy FluorescenceQuantum dotBiocompatibilityPerylenetetracarboxylic anhydride.EuropiumCarbon
researchProduct

The Ba2LnFeNb4O15 “tetragonal tungsten bronze”: Towards RT composite multiferroics

2009

Several Niobium oxides of formula Ba2LnFeNb4O15 (Ln = La, Pr, Nd, Sm, Eu, Gd) with the Tetragonal Tungsten Bronze (TTB) structure have been synthesised by conventional solid-state methods. The Neodymium, Samarium and Europium compounds are ferroelectric with Curie temperature ranging from 320 to 440K. The Praseodymium and Gadolinium compounds behave as relaxors below 170 and 300 K respectively. The Praseodymium, Neodymium, Samarium, Europium and Gadolinium compounds exhibit magnetic hysteresis loops at room temperature originating from traces of a barium ferrite secondary phase. The presence of both ferroelectric and magnetic hysteresis loops at room temperature allows considering these mat…

Materials scienceCrystal-chemistryPraseodymium[ PHYS.COND.CM-MS ] Physics [physics]/Condensed Matter [cond-mat]/Materials Science [cond-mat.mtrl-sci]FOS: Physical scienceschemistry.chemical_elementMineralogy02 engineering and technology01 natural scienceschemistry.chemical_compoundTetragonal crystal system0103 physical sciencesMagnetic propertiesGeneral Materials ScienceMultiferroicsBarium ferriteTetragonal tungsten bronzeComposites010302 applied physicsCondensed Matter - Materials ScienceMultiferroic propertiesMaterials Science (cond-mat.mtrl-sci)General Chemistry021001 nanoscience & nanotechnologyCondensed Matter PhysicsFerroelectricitySamariumCrystallographychemistryDielectric properties[PHYS.COND.CM-MS]Physics [physics]/Condensed Matter [cond-mat]/Materials Science [cond-mat.mtrl-sci]Curie temperature0210 nano-technologyEuropiumSolid state Chemistry
researchProduct

Effect of the dopant selection (Er, Eu, Nd or Ce) and its quantity on the formation of yttrium aluminum garnet nanopowders

2008

Abstract Hydroxide precursors, synthesized using the co-precipitation method, were calcined for 1 h at the temperatures of 900, 1000 and 1100 °C, respectively, and heated directly to 1500 °C to produce various Y 3 Al 5 O 12 (YAG) nanopowders with different doping quantities of erbium, europium, neodymium and cerium. All samples were investigated using thermo-gravimetry (TG) and differential thermal analysis (DTA), field emission gun-scanning electron microscopy (FEG-SEM), transmission electron microscopy (TEM) and X-ray diffraction (XRD). TG and DTA experiments were performed from room temperature up to 1500 °C; the weight loss curves combined with the presence of exo- and endo-thermal even…

Materials scienceDopantOrganic ChemistryAnalytical chemistrychemistry.chemical_elementMineralogyNd:YAGYttriumEr:YAGRietveld methodNeodymiumAtomic and Molecular Physics and OpticsNanocrystalline materialElectronic Optical and Magnetic MaterialsInorganic ChemistryCeriumLattice constantchemistryDifferential thermal analysisCe:YAG nanopowderElectrical and Electronic EngineeringPhysical and Theoretical ChemistryEu:YAGEuropiumSpectroscopyOptical Materials
researchProduct

Study of the Dielectric Properties of Europium Doped Barium Titanate Ceramics by an Impedance Spectroscopy

2015

The barium titanate (BaTiO3) and the BaTiO3 + 0.1wt.% Eu2O3 ceramics were prepared by a conventional ceramic method. The structural studies were carried out by means of an X-ray diffraction technique. The influence of the grains and the grain boundaries on the electrical properties was investigated using a impedance spectroscopy. This technique enables us to determine the values of grain and grain boundary resistance. The results show that the Eu doping leads to a significant reduction in the resistance value of the grains (˜105Ω) with respect to the pure BT ceramics (˜107Ω). The conductivity processes were determined from the Arrhenius behaviour of grain and grain boundary resistances.

Materials scienceDopingchemistry.chemical_elementDielectricConductivityCondensed Matter PhysicsElectronic Optical and Magnetic MaterialsDielectric spectroscopychemistry.chemical_compoundchemistryvisual_artBarium titanatevisual_art.visual_art_mediumGrain boundaryCeramicComposite materialEuropiumFerroelectrics
researchProduct

Hackmanite—The Natural Glow-in-the-Dark Material

2020

“Glow-in-the-dark” materials are known to practically everyone who has ever traveled by airplane or cruise ship, since they are commonly used for self-lit emergency exit signs. The green afterglow, persistent luminescence (PeL), is obtained from divalent europium doped to a synthetic strontium aluminate, but there are also some natural minerals capable of afterglow. One such mineral is hackmanite, the afterglow of which has never been thoroughly investigated, even if its synthetic versions can compete with some of the best commercially available synthetic PeL materials. Here we combine experimental and computational data to show that the white PeL of natural hackmanite is generated and cont…

Materials scienceGeneral Chemical Engineeringchemistry.chemical_element02 engineering and technologyNatural mineral010402 general chemistry01 natural sciencesNatural (archaeology)Synthetic materialsSODALITEchemistry.chemical_compoundPersistent luminescenceMaterials ChemistryTUGTUPITESPECTRACOLORluminesenssiIRONStrontium aluminate[CHIM.MATE]Chemical Sciences/Material chemistryOPTICAL-PROPERTIESGeneral ChemistryRESONANCE021001 nanoscience & nanotechnology0104 chemical sciencesAfterglow[CHIM.THEO]Chemical Sciences/Theoretical and/or physical chemistryCENTERSPhysics and AstronomychemistryChemical physicsLUMINESCENCE0210 nano-technologyEuropiumLuminescenceChemistry of Materials
researchProduct